Therefore, we attempted to distinguish a miRNA regulated RanGAP1 expression and IM efficacy in CML cells through blocking of nuclear BCR-ABL protein export to the cytoplasm. Here, RANGAP1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.